Deadly interactions: Synergistic manipulations of concurrent pathogen infections potentially enabling future pandemics
- PMID: 37660981
- DOI: 10.1016/j.drudis.2023.103762
Deadly interactions: Synergistic manipulations of concurrent pathogen infections potentially enabling future pandemics
Abstract
Certain mono-infections of influenza viruses and novel coronaviruses, including severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) are significant threats to human health. Concurrent infections by influenza viruses and coronaviruses increases their danger. Influenza viruses have eight manipulations capable of assisting SARS-CoV-2 and other coronaviruses, and several of these manipulations, which are not specific to viruses, can also directly or indirectly boost dangerous secondary bacterial pneumonias. The influenza virus manipulations include: inhibiting transcription factors and cytokine expression; impairing defensive protein expression; increasing RNA viral replication; inhibiting defenses by manipulating cellular sensors and signaling pathways; inhibiting defenses by secreting exosomes; stimulating cholesterol production to increase synthesized virion infectivities; increasing cellular autophagy to assist viral replication; and stimulating glucocorticoid synthesis to suppress innate and adaptive immune defenses by inhibiting cytokine, chemokine, and adhesion molecule production. Teaser: Rapidly spreading multidrug-resistant respiratory bacteria, combined with influenza virus's far-reaching cellular defense manipulations benefiting evolving SARS-CoV-2 or other coronaviruses and/or respiratory bacteria, can enable more severe pandemics or co-pandemics.
Keywords: alveolar epithelial cells; bacterial pneumonia; concurrent infections; coronavirus; influenza; respiratory pathogens.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Similar articles
-
Increased Fungal Infection Mortality Induced by Concurrent Viral Cellular Manipulations.Lung. 2023 Oct;201(5):467-476. doi: 10.1007/s00408-023-00642-6. Epub 2023 Sep 5. Lung. 2023. PMID: 37670187 Review.
-
Eight influenza virus cellular manipulations which can boost concurrent SARS-CoV-2 infections to severe outcomes.Hum Cell. 2023 Sep;36(5):1581-1592. doi: 10.1007/s13577-023-00923-5. Epub 2023 Jun 12. Hum Cell. 2023. PMID: 37306884 Review.
-
Lethal synergistic infections by two concurrent respiratory pathogens.Arch Med Res. 2024 Oct 24;56(1):103101. doi: 10.1016/j.arcmed.2024.103101. Online ahead of print. Arch Med Res. 2024. PMID: 39454459 Review.
-
Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic.Virol J. 2021 May 1;18(1):93. doi: 10.1186/s12985-021-01545-9. Virol J. 2021. PMID: 33933115 Free PMC article.
-
Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.Can Respir J. 2020 Sep 5;2020:1401053. doi: 10.1155/2020/1401053. eCollection 2020. Can Respir J. 2020. PMID: 32934758 Free PMC article. Review.
Cited by
-
Community-Based View on Diagnostic Imaging at the End of COVID-19 Pandemic: Online Survey-Assisted Study.Diagnostics (Basel). 2024 Jun 15;14(12):1269. doi: 10.3390/diagnostics14121269. Diagnostics (Basel). 2024. PMID: 38928684 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous